Track record · closed signal

UiPath Inc. (PATH) — closed signal from October 20, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 18, 2026 — -9.7% at the close.

Predicted vs. what happened

PATH price · publication thesis → realized outcomesplit-adjusted

$15.50 – $16.20Entry zone — fair-value band

$15.88Published — price the day we called it

$20.96Target — the price the thesis aimed for

$19.84Peak — highest point inside the window, not a realized return

$14.34Window close — end-of-window price, context only

What happened

Partial

Reached 78% of the predicted growth at its peak, without hitting the target.

At window close

-9.7%

realized, from the publication price to the last close inside the window

Peak gain

+24.9%

peak, from the publication price — not a realized return

S&P 500, same window

+3.3%

SPY over the identical days, dividend-adjusted

Window close

$14.34

last close inside the window, ended January 18, 2026

Peak price

$19.84

peak on December 8, 2025 — not a realized return

Days to target

—

The thesis — published October 20, 2025

Predicted growth

+32%

over the measurement window

Target price

$20.96

the price the thesis aimed for

Entry zone

$15.50 – $16.20

the fair-value band we waited for

Price at publication

$15.88

published October 20, 2025

Confidence

70%

how strongly the data lined up

Timeframe

Short-term (0–3 months)

UiPath builds AI tools that automate office work. New Maestro features and testing expand what the platform can do. With about $1.4B in cash and no debt, the company has room to execute. Lately, more buyers than usual and a rising recent average price point to near-term strength. After a fast rise, waiting for small dips could set up a 1-3 month move if volume stays high.

Primary drivers

Regular AI feature releases like Maestro expand what the software can do.
More buyers than usual and steady upward price action support momentum.
Large cash balance and no debt give room to invest and improve the product.
More companies want to automate routine work, lifting long-term demand.

How it played out

PATH: target missed after a 24.9% peak gain

Lyra published PATH at $15.88 on 2025-10-20 for a short-term window through 2026-01-18. The thesis expected 32% growth. It pointed to regular artificial-intelligence feature releases such as Maestro, stronger buyer interest, steady upward price action, a large cash balance with no debt, and demand for routine-work automation.

Inside the window, PATH rose to $19.84 on 2025-12-08, a 24.9% peak gain. That peak stayed below the $20.96 target. It never got there. By 2026-01-18, PATH ended at $14.34. The thesis partly played out on the rise, but missed the target and faded by the close.

What happened during the window

On 2025-12-05, ITPro reported that UiPath partnered with Veeva to streamline application testing and validation for life sciences customers.

UiPath partners with Veeva to streamline application testing and validation

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All PATH signals